Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-2-6
|
pubmed:abstractText |
The enantiomeric bioinversion of ketoprofen (KP) enantiomers and their incorporation into triacylglycerols were investigated in the rat (1) in vitro, using liver homogenates, subcellular fractions, and hepatocytes, and (2) in vivo, in different tissue samples after oral administration of the radiolabelled compounds. In liver homogenates or subcellular fractions, the enantiomer (S)-ketoprofen (S-KP) was recovered unchanged, whereas (R)-ketoprofen (R-KP) was partially converted into its Coenzyme A (CoA) thioester and inverted to S-KP. Both processes occurred mainly in the mitochondrial fraction. This supports the mechanism of inversion via stereoselective formation of CoA thioester of R-KP, already described for other non-steroidal anti-inflammatory drugs. Incorporation into triacylglycerols was detected after incubation with intact hepatocytes in the presence of added glycerol. The process was stereoselective for R-KP vs. S-KP (covalently bound radioactivity 26,742 +/- 4,665 dpm/10(6) cells vs. 6,644 +/- 3,179 dpm/10(6) cells, respectively). However, no incorporation was found in liver samples after oral administration of either R-KP or S-KP. On the contrary, in adipose tissue samples a significant and stereoselective formation of hybrid triacylglycerols was observed: 11,076 +/- 2,790 dpm.g-1 for R-KP vs. 660 +/- 268 dpm.g-1 for S-KP. The incorporated R/S ratio, higher in adipose tissue (R/S = 17) than in hepatocytes (R/S = 4), indicates that fat may be the main tissue store for the xenobiotic R-KP in rats.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0899-0042
|
pubmed:author |
pubmed-author:CabriJJ,
pubmed-author:CarabazaAA,
pubmed-author:CarganicoGG,
pubmed-author:GarciaA MAM,
pubmed-author:GomezMM,
pubmed-author:GutierrezMM,
pubmed-author:MauleonDD,
pubmed-author:MirSS,
pubmed-author:MontserratXX,
pubmed-author:OrtegaEE,
pubmed-author:PascualJJ,
pubmed-author:SuesaNN,
pubmed-author:TosiII
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
163-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8857179-Adipose Tissue,
pubmed-meshheading:8857179-Animals,
pubmed-meshheading:8857179-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:8857179-Coenzyme A,
pubmed-meshheading:8857179-Ketoprofen,
pubmed-meshheading:8857179-Liver,
pubmed-meshheading:8857179-Male,
pubmed-meshheading:8857179-Rats,
pubmed-meshheading:8857179-Rats, Sprague-Dawley,
pubmed-meshheading:8857179-Stereoisomerism,
pubmed-meshheading:8857179-Triglycerides
|
pubmed:year |
1996
|
pubmed:articleTitle |
Stereoselective metabolic pathways of ketoprofen in the rat: incorporation into triacylglycerols and enantiomeric inversion.
|
pubmed:affiliation |
R&D Department, Laboratorios Menarini S.A., Badalona, Spain.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|